Latest News Archive

Please select Category, Year, and then Month to display items

International Award for UFS Department of Nuclear Medicine

07 July 2023 | Story André Damons | Photo Supplied

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

First postgraduate degree in Forensic Genetics in Africa

2010-03-19

At the launch were, from the left, front: Ms Christa Swanepoel (Applied Biosystems), Ms Karen Ehlers (Department of Genetics, UFS), Dr Carolyn Hancock and Ms Vanessa Lynch (both from DNA Project). Middle row: Dr. Sphie Mukwana (Director: Biotech Forensics, Kenya), Mr Pierre Joubert (Director: SAPS Forensic Science Laboratory) and Prof. Johan Spies (Chairperson: Department of Genetics, UFS). Back row: Mr Izak van Niekerk (Southern Cross Biotechnologies) and Mr Loen Ehlers (National Prosecution Authority).
Photo: Stephen Collett

The Department of Genetics at the University of the Free State (UFS) recently launched the first postgraduate degree offered by a tertiary institution in Forensic Genetics in Africa.

“We are at the beginning of something special. The UFS has developed the programme with the aim of providing graduates with the skills and knowledge they would require to work in the field of forensic biology. These graduates will be the first group of professionals that have undergone tertiary training in order to assist in the resolution of crime through forensic science in South Africa. It has also put the UFS in the forefront of training of this nature,” said Prof. Johan Spies, the departmental chairperson.

According to Mr Pierre Joubert, Director at the Forensic Science Laboratory (FSL) in Pretoria, students trained in this programme would easily be employed by the FSL since they would have the appropriate applied and technical training in forensic science.

Currently the FSL has no personnel with degrees in forensic science in its employ. It employs B.Sc. graduates in the fields of microbiology, genetics, molecular biology and biochemistry as forensic analysts. These employees then go through an extensive supplementary training programme for about six months.

Dr Sophie Mukwana, Director of Biotech Forensics in Kenya, said the launch of this programme in South Africa would benefit African countries like Kenya which relied on the USA for this kind of training. She said they hoped to partner with the UFS in this venture.

Applied Biosystems and Southern Cross Biotechnology have donated the necessary equipment to the UFS for this training.

“It is not only important that students should see the equipment but they should also know how to operate it,” said Ms Vanessa Lynch, from the DNA Project.

The DNA Project, in conjunction with the FSL and the UFS, has developed the learning materials which will be presented at the UFS from 2011.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za

19 March 2010

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept